Import D(-)A-P-Hydroxyphenylglycine — Buy in Bulk from Supplier in China

D(-)-p-hydroxyphenylglycine is a chiral amino acid intermediate used primarily in the synthesis of pharmaceuticals such as amoxicillin and cephalosporins. This compound features a para-hydroxyphenyl group attached to a glycine backbone, with optical purity critical for end-product efficacy. The supplier, Harbin Shidai Industry Trade Group Co Ltd, positions it as a high-purity intermediate suitable for GMP-regulated production environments.

The material is typically supplied as a white to off-white crystalline powder with a molecular formula of C8H9NO3 and a molecular weight of 167.16 g/mol. Standard industry grades for this compound include pharmaceutical-grade material with assay values exceeding 98%, low heavy metal content (typically below 10 ppm for lead and cadmium) and controlled residual solvent levels per ICH guidelines. It is soluble in water and polar organic solvents, which facilitates its use in aqueous synthesis routes.

Pharmaceutical manufacturers source this intermediate for beta-lactam antibiotic production, while fine chemical producers use it in specialty syntheses. Buyers typically request 25 kg fiber drums with double polyethylene liners for export shipments. Confirmation of optical rotation ([α]D20 typically -155° to -165° in 1N HCl) and chiral purity via HPLC is standard practice before commercial-scale orders. The supplier’s location in Harbin, Heilongjiang, offers logistics access to major Chinese ports for international distribution.

Harbin Shidai Industry Trade Group Co Ltd operates from No 186 Xiangfang Street in the Xiangfang District of Harbin, Heilongjiang Province, China. The company is classified as an imported-tier supplier with a harbor trust tier, indicating established trade credentials for cross-border transactions. Its address places it in a key industrial zone with access to rail and port logistics for bulk chemical shipments.

The supplier’s profile does not disclose response metrics, certifications, or production capacity, so buyers should verify these details directly. The company focuses on pharmaceutical intermediates and specialty chemicals, with D(-)-p-hydroxyphenylglycine representing a core product in its portfolio. No additional information about facility size, workforce, or regulatory approvals is provided in the listing, requiring direct confirmation for quality compliance.